Dyne Therapeutics

Youtube Subscribe

Open: 11.98 Close: 11.63 Change: -0.35

Our AI found unexpected things about Dyne Therapeutics Company Inc.

Are looking for the most relevant information about Dyne Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Dyne Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Dyne Therapeutics are: Dyne, Therapeutics, price, stock, upgrade, NASDAQ, DYN, and the most common words in the summary are: therapeutic, pharmaceutical, inc, united, state, dyne, pharma, . One of the sentences in the summary was: Raymond James raised the price target to $27 from $16.00. Other …

Concept Map

Semantic Network

Stock Summary

Dyne Therapeutics, Inc. focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company develops programs for myotonic dystrophy type 1, duchenne muscular dystroppy, and.

Today's Summary

Raymond James has upgraded Dyne Therapeutics Inc (NASDAQ: DYN) from Outperform to Strong Buy. Raymond James raised the price target to $27 from $16.00. The average of price targets set by Wall Street analysts indicates a potential upside.

Today's News

Dyne Therapeutics net change in intangible assets from 2020 to 2023. We have provided a few examples below that you can copy and paste. Raymond James has upgraded Dyne Therapeutics Inc (NASDAQ: DYN) from Outperform to Strong Buy and raised the price target to $27 from $16. The average of price targets set by Wall Street analysts indicates a potential upside of 84% in Dyne Dyne Therapeutics Stock (NASDAQ:DYN), Quotes and News Summary DyneTherapeutics stock price, news, charts, stock research, profile, profile. The stock price for Dynetherapeutics ( NASDAQ : DYN ) is $ 11.63 last updated Today at July 12, 2023. Dyne Therapeutics hiring Associate Director, IT End User Support & Systems in Waltham, Massachusetts, United States. StockNews.com upgraded shares from a “sell” rating to a ‘hold’ rating in a research note on Friday.

Stock Profile

"Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts."

Keywords

This document will help you to evaluate Dyne Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Dyne Therapeutics are: Dyne, Therapeutics, price, stock, upgrade, NASDAQ, DYN, and the most common words in the summary are: therapeutic, pharmaceutical, inc, united, state, dyne, pharma, . One of the sentences in the summary was: Raymond James raised the price target to $27 from $16.00. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #pharmaceutical #inc #united #state #dyne #pharma.

Read more →

Youtube Subscribe

---